adBlockCheck

medicine

How Clinical Trials Work

Prescription medications undergo rigorous rounds of testing and approval before hitting the consumer market. The Onion breaks down the steps involved in this process

FDA Approves Female-Libido-Enhancing Man

WASHINGTON—In an effort to address the needs of women suffering from a lack of sexual desire, the FDA announced Tuesday that it had approved a new female-libido-enhancing man, which is expected to be made available to the general public by year’s end.

Pfizer Mercifully Puts Down Another Batch Of Trial Patients

NEW YORK—Following unforeseen complications during a trial of the company’s new cholesterol medication Lipodrin, researchers at pharmaceutical manufacturer Pfizer said they were forced to put down another batch of test patients out of mercy Fr...

Benadryl Introduces New Non-Drowsy Allergy Dart

NEW BRUNSWICK, NJ—Promising consumers rapid relief from seasonal allergies without any drowsiness, Johnson & Johnson announced the release Friday of Benadryl Pierce, a new blowgun-administered antihistamine dart that will soon be available in dr...

FDA Approves New Drug For Treating Pill Deficiencies

WASHINGTON—In what is being considered a major breakthrough for the millions of Americans suffering from a severe lack of capsules and tablets, the FDA announced Friday that it had approved a new drug for treating pill deficiencies.

Pfizer Releases Vintage Cask-Aged Robitussin

GROTON, CT—Touting the new offering’s full-bodied flavor and bold, fruit-forward bouquet, pharmaceutical giant Pfizer unveiled a vintage cask-aged variety of its popular cold medicine Robitussin on Friday. Labeled as Robitussin Reserve, the hi...

How To Protect Yourself Against Ebola

This week saw the first confirmed case of Ebola virus within the United States, the latest development in an outbreak that has already claimed over 3,000 lives.

Visit To Doctor Splurged On

WILMINGTON, DE—Admitting that it has been a long time since he’s allowed himself such an indulgence, local 26-year-old Greg Burnet told reporters Thursday that he recently decided to splurge on an appointment with his general practitioner.
End Of Section
  • More News

Sweating, Shaking Pharmaceutical CEO Says He Can Stop Profiting Off Opioid Epidemic Anytime He Wants

PHILADELPHIA—Visibly trembling as he wiped beads of perspiration from his forehead, Arcelis Pharmaceuticals CEO Paul Corrier told reporters Wednesday that he could stop profiting off the nation’s opioid crisis anytime he wants. “Getting these lethally addictive drugs into the hands of vulnerable communities across the country is just something I do from time to time for a little profit—I can drop it whenever I choose,” said Corrier, clawing at his sweat-drenched shirt as he insisted he could “quit in a heartbeat” if generating billions in revenue by misleading the public about the dangers of opioids ever got out of hand. “Sure, every now and then I’ll launch an aggressive marketing campaign aimed at getting doctors to overprescribe fentanyl sprays, but it’s honestly not a big deal. Seriously, it’s fine. Just because I’ll occasionally partake in making money off the devastation wrought by drugs hundreds of times more potent than morphine doesn’t mean it controls me.” At press time, Corrier had collapsed in a boardroom meeting and was choking on his own tongue after hearing the projected profit margins for a secondary medication used to treat opioid-related insomnia.

More from this section

Benadryl Introduces New Non-Drowsy Allergy Dart

NEW BRUNSWICK, NJ—Promising consumers rapid relief from seasonal allergies without any drowsiness, Johnson & Johnson announced the release Friday of Benadryl Pierce, a new blowgun-administered antihistamine dart that will soon be available in dr...

Sign up For The Onion's Newsletter

Give your spam filter something to do.

Close